Cargando…
The prohibitin-repressive interaction with E2F1 is rapidly inhibited by androgen signalling in prostate cancer cells
Prohibitin (PHB) is a tumour suppressor molecule with pleiotropic activities across several cellular compartments including mitochondria, cell membrane and the nucleus. PHB and the steroid-activated androgen receptor (AR) have an interplay where AR downregulates PHB, and PHB represses AR. Additional...
Autores principales: | Koushyar, S, Economides, G, Zaat, S, Jiang, W, Bevan, C L, Dart, D A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5523065/ https://www.ncbi.nlm.nih.gov/pubmed/28504694 http://dx.doi.org/10.1038/oncsis.2017.32 |
Ejemplares similares
-
Prohibitin Links Cell Cycle, Motility and Invasion in Prostate Cancer Cells
por: Koushyar, Sarah, et al.
Publicado: (2023) -
Reducing prohibitin increases histone acetylation, and promotes androgen independence in prostate tumours by increasing androgen receptor activation by adrenal androgens
por: Dart, D. A., et al.
Publicado: (2011) -
Manipulating prohibitin levels provides evidence for an in vivo role in androgen regulation of prostate tumours
por: Dart, D Alwyn, et al.
Publicado: (2009) -
CaMK IV phosphorylates prohibitin 2 and regulates prohibitin 2-mediated repression of MEF2 transcription
por: Sun, Luguo, et al.
Publicado: (2011) -
Prohibitin is required for transcriptional repression by the WT1-BASP1 complex
por: Toska, Eneda, et al.
Publicado: (2013)